Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

J Christopher Coughlin

Affiliations

  • Director at Prestige Consumer Healthcare Inc. (PBH), 2019-08-01
  • Director at Alexion Pharmaceuticals Inc. (ALXN), 2019-05-17
  • Director at Allergan Plc (AGN), 2019-05-03
  • Director at Dun & Bradstreet Corp (DNB), 2017-03-13
  • Director at Hologic Inc (HOLX), 2017-03-09
  • Director at Covidien Plc (COV), 2015-01-28
  • Director at Forest Laboratories Llc (FRX), 2014-07-03
  • Director at Dipexium Pharmaceuticals Inc. (DPRX), 2014-03-20
  • Evp And Cfo at Tyco International Ltd (TYC), 2010-11-30
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AGN $190.63 300 Director 16,431 2018-09-06 Filing
AGN $190.64 517 Director 16,131 2018-09-06 Filing
AGN $190.68 4,889 Director 15,614 2018-09-06 Filing
AGN $190.67 222 Director 10,725 2018-09-06 Filing
AGN $190.66 816 Director 10,503 2018-09-06 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
DNB $112.50 2,330 Director 15,057 2015-11-06 Filing
DNB $110.75 4,319 Director 12,543 2013-11-12 Filing
COV $62.05 36,000 Director 0 2013-02-05 Filing